Vialwirebiotech, curated
October 2, 2026, 6:01 AM
June 14, 2026
- 6:00 AM · The Guardian — Science6:00 AMLondon startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’ — The Guardian — Science
June 13, 2026
- 1:06 AM · SCMP — Tech1:06 AMUS blocks foreign access to Anthropic’s newest AI models over security risks — SCMP — Tech
June 12, 2026
- 12:00 PM · Pharmaceutical Executive12:00 PM<![CDATA[Zepzelca Fails to Meet Main Goal of Phase III Lagoon Trial in Second-Line Small Cell Lung Cancer]]> — Pharmaceutical Executive
- 12:00 PM · BioWorld12:00 PMChina partnerships drive biopharma’s biggest deal month since 2023 — BioWorld
- 12:00 PM · BioWorld12:00 PMStreet canvu MBX phase II HP data more than one way — BioWorld
- 9:31 AM · BioPharma Dive9:31 AMRapport ‘fully prepared’ to launch seizure drug solo, CEO says — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMShanghai Ruotuo Biotechnology discovers new anti-EGFR/HER3 ADCs — BioWorld
- 9:00 AM · BioWorld9:00 AMJW Pharmaceutical’s DDC-02 improves cognitive function — BioWorld
- 9:00 AM · BioWorld9:00 AMFortvita and Innovent patent new anti-TROP2/B7-H4 ADCs — BioWorld
- 9:00 AM · BioWorld9:00 AMThryv Therapeutics synthesizes SGK1 inhibitors — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMChangchun Genescience Pharmaceuticals identifies new FGFR2/3 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMHengrui Pharmaceuticals reports new BCL6 degradation inducers — BioWorld
- 9:00 AM · BioWorld9:00 AMApplied Biologics begins osteoarthritis research program — BioWorld
- 7:00 AM · Drug Discovery World7:00 AMLaverock reports positive data from oncology programmes — Drug Discovery World